Chemoprophylaxis of Influenza A (H1N1) in the perspective of the Brazilian Unified Health System (SUS): a budget impact analysis
BACKGROUND: In Brazil, the prophylaxis of influenza with the antivirals oseltamivir and zanamivir is cost-effective and recommended for the groups with higher risk of complications. In this study we estimated the impact of the chemoprophylaxis in the health system budget from 2017 to 2023. METHODS:...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | Portuguese |
| Published: |
Universidade Estadual de Campinas
2019
|
| Subjects: | |
| Online Access: | https://econtents.sbu.unicamp.br/eventos/index.php/pibic/article/view/2827 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | BACKGROUND: In Brazil, the prophylaxis of influenza with the antivirals oseltamivir and zanamivir is cost-effective and recommended for the groups with higher risk of complications. In this study we estimated the impact of the chemoprophylaxis in the health system budget from 2017 to 2023. METHODS: We calculated the size of the risk population, expenditure with prophylaxis and the budget impact in 2017 to 2018 with official demographic and vaccine coverage data, and aqcuisition of antivirals by SUS. The estimative from 2019 to 2023 was conducted using trigonometric models. RESULTS AND CONCLUSION: The risk population variated from 2.3 to 5.5 millions of individuals and the budget impact variated from 0.74% (2018) and 6.9% (2019). |
|---|---|
| ISSN: | 2596-1969 |
